Article Figures & Data
Tables
- Table 1
- Methicillin-resistant Staphylococcus aureus isolate and patient characteristics.
Characteristics n (%) Total number of isolates 49 Male gender 33 (67.3) Age, years 0-4 8 (16.3) 5-19 6 (12.3) 20-39 16 (32.7) 40-49 6 (12.3) 50-59 2 (4.1) 60-69 7 (14.3) 70-79 3 (6.1) ≥80 1 (2.0) Source Respiratory 7 (14.3) Blood 5 (10.2) Urine 2 (4.1) Wound 27 (55.1) Body fluid 2 (4.1) Tissue 1 (2.1) Swab 5 (10.2) Infection type ICU 1 (2.1) ICU: intensive care unit MIC (mg/L) No. of isolates Percentage MIC50 MIC90 MIC50/90 0.75 8 16.3 1 1.5 0.7 1 23 46.9 1.5 15 30.6 2 3 6.1 MIC: minimum inhibitory concentration, No: number, MRSA: Methicillin-resistant Staphylococcus aureus Characteristics n (%) Total number of isolates 99 Male gender 54 (54.5) Age, years 0-4 12 (12.1) 5-19 7 (7.1) 20-39 18 (18.2) 40-49 2 (2.0) 50-59 16 (16.2) 60-69 13 (13.1) 70-79 19 (19.2) ≥80 12 (12.1) Source Respiratory 42 (42.4) Blood 0 (0.0) Urine 24 (24.2) Wound 22 (22.2) Body fluid 7 (7.1) Tissue 3 (3.0) Swab 1 (1.0) Infection type ICU 15 (15.2) P. aeruginosa: Pseudomonas aeruginosa, ICU: intensive care unit MIC (mg/L) No. of isolates Percentage MIC50 MIC90 MIC50/90 0.047 1 1.01 16 32 0.5 0.094 1 1.01 1 3 3.03 1.5 2 2.02 2 2 2.02 3 10 10.10 4 11 11.11 6 4 4.04 8 4 4.04 12 6 6.06 16 4 4.04 32 46 46.46 >32 5 5.05 MIC: minimum inhibitory concentration, MDR: multi-drug resistant, No: number, P. aeruginosa: Pseudomonas aeruginosa Antibiotic suitability pattern Total tested MDR P. aeruginosa Susceptible Resistant Ceftazidime 81 56 (56.6) 25 (25.6) Piperacillin/tazobactam 67 51 (51.5) 16 (16.2) Imipenem 50 11(11.1) 39 (39.4) Meropenem 47 10 (10.1) 37 (37.4) Gentamicin 80 50 (50.5) 30 (30.3) Tobramycin 63 50 (50.5) 13 (13.1) Amikacin 57 45 (45.5) 12 (12.1) Ciprofloxacin 81 55 (55.6) 26 (26.3) MDR P. aeruginosa: Multi-drug resistant Pseudomonas aeruginosa